151 related articles for article (PubMed ID: 6415730)
1. Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy.
Meltzer HY; Kolakowska T; Robertson A; Tricou BJ
Psychopharmacology (Berl); 1983; 81(1):37-41. PubMed ID: 6415730
[TBL] [Abstract][Full Text] [Related]
2. The behavioral toxicity of bromocriptine in patients with psychiatric illness.
Perovich RM; Lieberman JA; Fleischhacker WW; Alvir J
J Clin Psychopharmacol; 1989 Dec; 9(6):417-22. PubMed ID: 2574194
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation.
Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P
Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine and dopamine receptor stimulation.
Debono AG; Marsden CD; Asselman P; Parkes JD
Br J Clin Pharmacol; 1976 Dec; 3(6):977-82. PubMed ID: 22216518
[TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia: clinical and neuroendocrine response to low dose bromocriptine.
Lenox RH; Weaver LA; Saran BM
J Clin Psychopharmacol; 1985 Oct; 5(5):286-92. PubMed ID: 4044881
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine in the treatment of the alcohol-withdrawal syndrome.
Borg V; Weinholdt T
Acta Psychiatr Scand; 1982 Feb; 65(2):101-11. PubMed ID: 6764859
[TBL] [Abstract][Full Text] [Related]
7. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
[TBL] [Abstract][Full Text] [Related]
8. Prolactin response to submaximal stimulation by TRH in nonaffective psychoses.
Spoov J; Bredbacka PE; Appelberg B; Katila H; Karonen SL; Rimón R; Sarna S
Biol Psychiatry; 1991 Feb; 29(3):204-10. PubMed ID: 1673063
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S
J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
[TBL] [Abstract][Full Text] [Related]
10. Effect of bromocriptine on maturity onset diabetes.
Barnett AH; Chapman C; Gailer K; Hayter CJ
Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
[TBL] [Abstract][Full Text] [Related]
11. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and premenstrual tension: a clinical and hormonal study.
Andersch B; Hahn L
Pharmatherapeutica; 1982; 3(2):107-13. PubMed ID: 7201645
[TBL] [Abstract][Full Text] [Related]
13. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
Barrera CM; Ruiz AE; Banks WA
Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
[TBL] [Abstract][Full Text] [Related]
14. Resistance to bromocriptine in prolactinomas.
Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
[TBL] [Abstract][Full Text] [Related]
15. Drugs five years later. Bromocriptine.
Vance ML; Evans WS; Thorner MO
Ann Intern Med; 1984 Jan; 100(1):78-91. PubMed ID: 6229205
[TBL] [Abstract][Full Text] [Related]
16. Effect of bromocriptine on serum hormones in acromegaly.
Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Parkes JD; Debono AG; Marsden CD
J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
[TBL] [Abstract][Full Text] [Related]
18. Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
Tollin SR
J Endocrinol Invest; 2000 Dec; 23(11):765-70. PubMed ID: 11194712
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
Werner S; Hall K; Sjöberg HE
Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
Stracke H; Heinlein W; Horowski R; Schatz H
Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
